Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 20, 2000
Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens
T Schulz-Utermoehl, R J Edwards, A R Boobis
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2000
Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody
T Schulz-Utermoehl, R J Mountfield, K Madsen, et al.
Journal of Pharmacological and Toxicological Methods
|
August 30, 2005
A semi-automated method for measuring the potential for protein covalent binding in drug discovery
S H Day, A Mao, R White, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2000
Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody
T Schulz-Utermoehl, R J Mountfield, R P Bywater, et al.
Pharmacogenetics
|
September 2, 1999
Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression
T Schulz-Utermoehl, A J Bennett, S W Ellis, et al.
Biochimica Et Biophysica Acta
|
March 21, 2001
Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies
T G Schulz, R Thiel, D Neubert, et al.
Brain Research
|
March 20, 1999
Expression and localisation of CYP2D enzymes in rat basal ganglia
A G Riedl, P M Watts, R J Edwards, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 20, 2000
Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens
T Schulz-Utermoehl, R J Edwards, A R Boobis
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2000
Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody
T Schulz-Utermoehl, R J Mountfield, K Madsen, et al.
Journal of Pharmacological and Toxicological Methods
|
August 30, 2005
A semi-automated method for measuring the potential for protein covalent binding in drug discovery
S H Day, A Mao, R White, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 20, 2000
Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody
T Schulz-Utermoehl, R J Mountfield, R P Bywater, et al.
Pharmacogenetics
|
September 2, 1999
Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression
T Schulz-Utermoehl, A J Bennett, S W Ellis, et al.
Biochimica Et Biophysica Acta
|
March 21, 2001
Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies
T G Schulz, R Thiel, D Neubert, et al.
Brain Research
|
March 20, 1999
Expression and localisation of CYP2D enzymes in rat basal ganglia
A G Riedl, P M Watts, R J Edwards, et al.
Page
of 1